New balloon treatment may replace surgery for early esophageal cancer
NCT ID NCT02558504
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two treatments for early-stage esophageal cancer in people with Barrett's esophagus: a new, less invasive procedure using radiofrequency ablation (a balloon that burns away abnormal cells) versus standard surgery to remove part of the esophagus. The goal was to see if the ablation could completely eliminate the cancer with fewer risks. The study involved 87 adults who were healthy enough for either treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospices Civils de Lyon, Hépatogastroentérologie, Pavillon H, Hôpital Edouard Herriot
Lyon, 69003, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a swallowed balloon unlock the genetic secrets of esophageal cancer?
- Light-Activated therapy shows promise for tumor control without surgery
- Massive study sheds light on esophageal cancer surgery outcomes
- New bipolar knife could make esophageal surgery safer
- 8,000-Patient study aims to sharpen cancer radiation with Real-Time MRI
- App-Based rehab after cancer surgery shows promise in small study